| 000 | 01393cam a22003495i 4500 | ||
|---|---|---|---|
| 005 | 20250919085751.0 | ||
| 008 | 161208s2015 nyua 000 0 eng | ||
| 020 |
_a9781634836005 (hardcover) _cRM961.40 |
||
| 039 | 9 |
_a201612291103 _bfadza _c201612291101 _dfadza _y12-08-2016 _zruzini |
|
| 040 |
_aDLC _beng _erda _cDLC _dUKM |
||
| 090 | _aQV77.5.S531m 2016 9 | ||
| 090 |
_aQV77.5 _b.S531m 2016 9 |
||
| 100 | 1 |
_aSharma, Sushil K., _eauthor. |
|
| 245 | 1 | 0 |
_aMonoamine oxidase inhibitors : _bclinical pharmacology, benefits, and potential health risks / _cSushil K. Sharma. |
| 264 | 1 |
_aHauppauge, New York : _bNova Science Publishers, Inc., _c2016. |
|
| 264 | 4 | _c©2016. | |
| 300 |
_a408 pages : _billustrations ; _c26 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 | _aPharmacology - research, safety testing and regulation | |
| 650 | 2 |
_aMonoamine Oxidase Inhibitors _xTherapeutic Use. |
|
| 830 | 0 | _aPharmacology - research, safety testing and regulation | |
| 907 |
_a.b16395384 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV77.5.S531m 2016 9 |
||
| 914 | _avtls003613632 | ||
| 990 | _amfh | ||
| 991 | _aProgram Sains Bioperubatan, PDAL, KKL | ||
| 998 |
_ad _b2016-08-12 _cm _da _feng _gnyu _y0 _z.b16395384 |
||
| 999 |
_c612929 _d612929 |
||